1-5-dihydro-7-(1-piperidinyl)-imidazo(2-1-b)quinazolin-2(3h)-one and Coronary-Disease

1-5-dihydro-7-(1-piperidinyl)-imidazo(2-1-b)quinazolin-2(3h)-one has been researched along with Coronary-Disease* in 1 studies

Other Studies

1 other study(ies) available for 1-5-dihydro-7-(1-piperidinyl)-imidazo(2-1-b)quinazolin-2(3h)-one and Coronary-Disease

ArticleYear
[The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cilostazol; Coronary Disease; Coronary Thrombosis; Cyclic AMP; Dipyridamole; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Tetrazoles

1989